Davis Polk
William A. Curran
- Deals
- 10
- Latest
- Jun 2026
- Most deals in
- Medtech
Firm
- Davis Polk Law firm · 2026 · 10 deals
Often works with
- David R. Bauer 4 deals together
- Veronica M. Wissel 3 deals together
- Pritesh P. Shah 3 deals together
- Adam Kaminsky 3 deals together
- Harold Birnbaum 2 deals together
- Adam Pukier 2 deals together
- Matthew Yeowart 2 deals together
- William J. Chudd 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | TARGAN | – | Merck Animal Health | Acquisition | Legal adviser to TARGAN (target) | Announced | – | Agtech+2 | Merck Animal Health acquisition of TARGAN |
| May 2026 | FMC India Private | FMC | Crystal Crop Protection | Acquisition | Legal adviser to FMC (target) | Announced | 252.0 | Chemicals+1 | Crystal Crop Protection acquisition of FMC India Private |
| May 2026 | two North American beverage closures compression molding facilities | Amcor | Closure Systems International Group | Asset sale | Legal adviser to Cerberus Capital Management and Closure Systems International Group (acquirer) | Announced | – | Packaging+1 | Closure Systems International Group acquisition of two North American beverage closures compression molding facilities |
| May 2026 | S+S Industries | – | Cerberus Capital Management, L.P. | Acquisition | Legal adviser to Cerberus Capital Management, L.P. (acquirer) | Announced | – | Data Centers+1 | Cerberus Capital Management, L.P. acquisition of S+S Industries |
| Mar 2026 | Agency lending business of Basis Multifamily Finance I | Basis Multifamily Finance I | Zions Bancorporation, N.A. | Asset sale | Legal adviser to Basis Investment Group, LLC and its subsidiary Basis Multifamily Finance I (target) | Completed | – | Real Estate+1 | Zions Bancorporation, N.A. acquisition of Agency lending business of Basis Multifamily Finance I |
| Mar 2026 | BVNK | – | Mastercard | Acquisition | Legal adviser to Mastercard (acquirer) | Completed | 1,800.0 | Payments Infrastructure+1 | Mastercard acquisition of BVNK |
| Feb 2026 | Uromedica | – | Coloplast A/S | Acquisition | Legal adviser to Coloplast A/S (acquirer) | Announced | – | Medtech | Coloplast A/S acquisition of Uromedica |
| Jan 2026 | AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 | AbelZeta | AstraZeneca | Asset sale | Legal adviser to AbelZeta (target) | Announced | 630.0 | Biotech+2 | AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 |
| Jan 2026 | Mentee Robotics | – | Mobileye Global | Acquisition | Legal adviser to Mobileye Global (acquirer) | Announced | 900.0 | AI+1 | Mobileye Global acquisition of Mentee Robotics |
| Jan 2026 | Conformal Medical | – | W. L. Gore & Associates | Acquisition | Legal adviser to W. L. Gore & Associates (acquirer) | Announced | – | Medtech+1 | W. L. Gore & Associates acquisition of Conformal Medical |
Deals where William A. Curran is named on the firm's deal team, by the firm or the press.